Next Article in Journal
A Review of Vitamin D Deficiency in the Critical Care Population
Previous Article in Journal
Systems for Quality Assurance in Pharmacy Education and Training in the European Union
Pharmacy 2014, 2(1), 27-39; doi:10.3390/pharmacy2010027

Pharmacist’s Use of Screening Tools to Estimate Risk of CVD: A Review of the Literature

1 Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork 30, Ireland 2 Department of Pharmacy, Mercy University Hospital, Grenville Place, Cork 30, Ireland
* Author to whom correspondence should be addressed.
Received: 19 August 2013 / Revised: 29 November 2013 / Accepted: 6 December 2013 / Published: 9 January 2014
View Full-Text   |   Download PDF [534 KB, uploaded 9 January 2014]   |  


To review pharmacist-led screening programmes for estimation of cardiovascular disease (CVD) risk using validated screening tools, studies were identified using a search of the following electronic databases: PubMed, EMBASE, Web of Knowledge and the Cochrane library databases. Each database was searched from inception to December 2011. The search terms used were: “cardiovascular disease”, “screening”, “risk estimation”, “pharmacist” and “pharmacy”. Titles, abstracts and full manuscripts were screened to determine eligibility. Inclusion criteria were: (i) Pharmacist-led CVD screening; and (ii) Use of validated screening tool or tools for CVD. From each included study information was collected on the following: Study author; year of publication; setting; inclusion and exclusion criteria; tools used and outcomes measured. Articles were grouped and independently verified to ensure they met with the inclusion criteria. Over 7,000 citations were found. Twenty full-length articles were retrieved for analysis, of which twelve were excluded, as they did not meet the inclusion criteria. The eight remaining articles were included in this literature review. Whilst pharmacists undertake screening in their own practice, this approach will only go so far. To have a population-health impact, pharmacists should be involved in proactive screening in a variety of settings.
Keywords: CVD; pharmacist; screening tools; review CVD; pharmacist; screening tools; review
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

O'Donovan, D.O.; Byrne, S.; Sahm, L.J. Pharmacist’s Use of Screening Tools to Estimate Risk of CVD: A Review of the Literature. Pharmacy 2014, 2, 27-39.

View more citation formats

Related Articles

Article Metrics


[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert